Skip to main content
R

Regent Pacific Group Limited — Investor Relations & Filings

Ticker · 575 ISIN · KYG3042R1314 LEI · 549300TF362HOIC4TJ34 HKEX Financial and insurance activities
Filings indexed 1,259 across all filing types
Latest filing 2022-08-02 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 575

About Regent Pacific Group Limited

http://www.regentpac.com

Regent Pacific Group Limited is an investment holding company primarily focused on the healthcare and life sciences sectors globally. The company specializes in growth and value-led investments, particularly targeting late-stage life sciences assets and biopharma companies. Its core strategy involves building a powerful portfolio of investments intended for commercialization, often achieved through out-licensing agreements with strategic pharmaceutical partners. Regent Pacific operates across key markets, including Europe, the United States, and the Asia Pacific region. A significant area of focus is the longevity medicine business, which utilizes advanced AI technology following the acquisition of Deep Longevity Inc., positioning the company as an engine for emerging AI-driven biopharma solutions.

Recent filings

Filing Released Lang Actions
Supplemental Announcement to the 2021 Annual Report
Regulatory Filings
2022-08-02 English
Change of Address of Hong Kong Branch Share Registrar and Transfer Office
Regulatory Filings
2022-07-26 English
Profit Warning
Regulatory Filings
2022-07-22 English
Next Day Disclosure Return
Regulatory Filings
2022-07-14 English
Deep Longevity published and granted the first microbiomic aging clock patent
Regulatory Filings
2022-07-06 English
Operational Update on Deep Longevity
Regulatory Filings
2022-07-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.